Canada markets closed

Alterity Therapeutics Limited (ATHE)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.2000+0.1300 (+6.28%)
At close: 04:00PM EDT
2.1106 -0.09 (-4.06%)
After hours: 06:25PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 20.62M
Enterprise Value 10.41M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)737.73
Price/Book (mrq)1.23
Enterprise Value/Revenue -1.18k
Enterprise Value/EBITDA -0.73

Trading Information

Stock Price History

Beta (5Y Monthly) 0.76
52-Week Change 3-22.79%
S&P500 52-Week Change 323.10%
52 Week High 35.4100
52 Week Low 31.5500
50-Day Moving Average 31.9596
200-Day Moving Average 32.3476

Share Statistics

Avg Vol (3 month) 386.73k
Avg Vol (10 day) 380.87k
Shares Outstanding 58.73M
Implied Shares Outstanding 64.46M
Float 82.54B
% Held by Insiders 10.00%
% Held by Institutions 11.00%
Shares Short (Apr 15, 2024) 490.28k
Short Ratio (Apr 15, 2024) 40.63
Short % of Float (Apr 15, 2024) 4N/A
Short % of Shares Outstanding (Apr 15, 2024) 41.03%
Shares Short (prior month Mar 15, 2024) 426.39k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jan 09, 2023

Financial Highlights

Currency in AUD.

Fiscal Year

Fiscal Year Ends Jun 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-348.40%

Management Effectiveness

Return on Assets (ttm)-28.94%
Return on Equity (ttm)-53.72%

Income Statement

Revenue (ttm)3.43M
Revenue Per Share (ttm)0.60
Quarterly Revenue Growth (yoy)-20.30%
Gross Profit (ttm)N/A
EBITDA -12.83M
Net Income Avi to Common (ttm)-12.28M
Diluted EPS (ttm)-1.9500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)12.32M
Total Cash Per Share (mrq)0
Total Debt (mrq)255.6k
Total Debt/Equity (mrq)1.45%
Current Ratio (mrq)4.89
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-14.61M
Levered Free Cash Flow (ttm)-9.95M